Skip to main navigation
Skip to content
Opiant_logo Opiant
Main Menu
  • Contact
  • Careers
  • About
    • Corporate Overview
    • Management Team
    • Board of Directors
    • Medical Advisory Board
    • Media
    • Careers
      • Culture at Opiant
  • Science & Technology
    • The Science of Addiction
    • Opioid Antagonists
    • Nasal Spray Delivery Technology
    • Antagonist for Acute Cannabinoid Overdose
    • Intellectual Property
    • Publications
  • Addiction Disorders
    • Overview
    • Opioid Use Disorder
    • Alcohol Use Disorder
    • Cannabinoid Use Disorder
  • Products & Pipeline
  • Patients & Families
    • Overview
    • Clinical Trials
    • External Resources
  • Investors
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • News Releases
    • Events and Presentations
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Financials & Filings
      • SEC Filings
      • Annual Reports & Proxy Statements
    • Investor Resources
      • Information Request
      • Contact IR
      • Email Alerts

Investors

Event Details

Opiant Pharmaceuticals Third Quarter 2019 Financial Results Conference Call

Nov 12, 2019 at 4:30 PM EST

Click here for webcast

Live Teleconference Information

Primary # -
877-407-0792
Secondary # -
201-689-8263
Passcode -
13695005
Print Page
RSS Feeds
Email Alerts
Contact IR

  • Privacy Policy
  • Site Map
© Opiant, 2020. All Rights Reserved.